Warner Chilcott Announces FDA Approval of New Ulcerative Colitis Product

DUBLIN, Ireland, Feb. 5, 2013 -- (Healthcare Sales & Marketing Network) -- Warner Chilcott plc (WCRX) today announced that the United States Food and Drug Administration (FDA) has approved its new 400 mg mesalamine product indicated for the treatment of ul... Biopharmaceuticals, Gastroenterology, FDAWarner Chilcott, DELZICOL, mesalamine, ulcerative colitis
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news